Single Visit Clinical Validation of ScreenFire, a Low-cost HPV Test

Plain-language summary

This study evaluates the clinical accuracy (validation) of ScreenFire, a low-cost HPV test, in a single visit. It compares the test with other methods (such as the careHPV test, colposcopy and biopsy) for cervical cancer screening. Women aged 30-59 were included. The study has no assigned phase and is currently active but not recruiting new participants.

The summary above is a plain-language rendering of the official record. The original English title is shown for reference.

Trial details

Phase

Not Applicable

Status

Active, not recruiting

Sponsor

The Cleveland Clinic

Intervention

ScreenFire HPV test, careHPV test, Colposcopy and biopsy, Gas-based cryotherapy, Thermal ablation

Start date

2/13/2023

Estimated completion

12/31/2027

Countries

El Salvador

Related genes

Locations

• San Salvador, El Salvador

Eligibility criteria

Criteria are reproduced from the ClinicalTrials.gov record in the original English. Only the trial team can determine eligibility.

Inclusion Criteria:

* Female, aged 30-59

Exclusion Criteria:

* Pregnancy at time of colposcopy/biopsy
* Hysterectomy with surgically absent cervix
* Cervical cancer screening in the past two years
* Prior diagnosis or treatment of invasive cervical cancer